EUVIMEDEUVIMED entdecken
Crossref

Managing QT prolongation in the Era of Coronavirus Disease 2019 (COVID-19)

Sidhi Laksono Purwowiyoto, Dony Yugo Hermanto, Muhammad Iqbal

Indonesian Journal of Cardiology · 2020

DOI: 10.30701/ijc.1002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Cardiology, 2020. Verfasst von Sidhi Laksono Purwowiyoto und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indonesia has declared a COVID-19 outbreaks because of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in March 2020. COVID-19 has significantly increased morbidity and mortality worldwide. Some studies have shown good clinical outcomes with the use of combination of chloroquine or hydroxychloroquine and azithromycin. That drugs can prolong the QT interval and increase the risk of Torsade de Pointes (TdP). The risk is increasing in several conditions such as in critical patients, metabolic disorders, sepsis, multiorgan dysfunction and with drug-drug interactions. Cardiologists need to know how to manage this condition to reduce the risk of TdP.

Zitieren

APA

Purwowiyoto, S. L., Hermanto, D. Y., & Iqbal, M. (2020). Managing QT prolongation in the Era of Coronavirus Disease 2019 (COVID-19). Indonesian Journal of Cardiology. https://doi.org/10.30701/ijc.1002

Vancouver

Purwowiyoto SL, Hermanto DY, Iqbal M. Managing QT prolongation in the Era of Coronavirus Disease 2019 (COVID-19). Indonesian Journal of Cardiology. 2020. doi:10.30701/ijc.1002

BibTeX
@article{Purwowiyoto2020,
  author = {Purwowiyoto, Sidhi Laksono and Hermanto, Dony Yugo and Iqbal, Muhammad},
  title = {Managing QT prolongation in the Era of Coronavirus Disease 2019 (COVID-19)},
  journal = {Indonesian Journal of Cardiology},
  year = {2020},
  doi = {10.30701/ijc.1002}
}
Kostenlos starten →